FDA Approval Could Send This Stock Soaring
Whenever the FDA approves a new drug... Timely investors could see 300-400% returns... ChemoCentryx soared 281% in the year after it won FDA approval... Immunogen jumped 449% in the two years after it won FDA approval... Even Krystal Biotech rose 242% when it looked like it would win FDA approval, which it did.

Financials
Curr Year EPS Estimate | 2.17 |
Next Quarter EPS Estimate | 0.67 |
Profit Margin | 7.18% |
Operating Margin | 10.20 |
Return on Assets | 0.08 |
Revenue | 36.7B |
Earnings Per Share | 2.31 |
Revenue Per Share | 32.32 |
Gross Profit | 8,709,699,584 |
Quarterly Revenue Growth | 0.04 |
General
Name | Starbucks Corp |
Ticker | SBUX |
Exchange | NASDAQ |
Sector | Consumer Cyclical |
Industry | Restaurants |
Currency | USD |
Country | USA |
Fiscal Year End | September |
Full Time Employees | 361,000 |
About Starbucks Corp
Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee, tea, and other beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks Coffee, Teavana, Seattle's Best Coffee, Ethos, and Starbucks Reserve brands. It partners with Global Food Banking Network support food security and reduce food waste. Starbucks Corporation was founded in 1971 and is based in Seattle, Washington.
Dividend
Starbucks Corp pays out a dividend of $2.44 per share, with a dividend yield of 2.88%.
SBUX's last dividend payment was made to shareholders on August 29, 2025.
They pay out 68.95% of their earnings out as a dividend.
Recent Dividends
Aug 29, 2025 | $0.61 |
May 30, 2025 | $0.61 |
Feb 28, 2025 | $0.61 |
Nov 29, 2024 | $0.61 |
Aug 30, 2024 | $0.57 |
May 31, 2024 | $0.57 |
Feb 23, 2024 | $0.57 |
Nov 24, 2023 | $0.57 |
Georgia farmers will get $531M in Hurricane Helene aid, but the deal's not done yet
ATLANTA (AP) — The wait continues for Georgia farmers who need more aid after , even as state and federal officials in other states announce agreements.
What's Going On With Amazon Stock Tuesday?
Amazon.com Inc (NASDAQ:AMZN) shares are trading lower on Tuesday despite multiple positive catalysts, including a new partnership with FanDuel and a bullish analyst initiation from Mizuho.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
What's Going On With Starbucks Stock Today?
Starbucks stock is steady as it opens a Bernabéu flagship in Madrid, while international comps were flat and Q3 International revenue rose 9% to $2B.
Distracted controllers allowed planes to come dangerously close on a San Diego runway, NTSB says
Investigators say that a private jet of crashing into a Southwest Airlines plane on a runway in San Diego two years ago because the air traffic controllers in the tower got distracted.
Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
Oracle Stock Is Rallying To Start The Week: What's Driving The Momentum?
Oracle Corporation (NASDAQ: ORCL) shares are trading higher and trending on Monday. Here's a look at what's going on.
Pilgrims turn Spain's Santiago de Compostela into the world's latest overtourism flashpoint
SANTIAGO DE COMPOSTELA, Spain (AP) — While some Barcelona residents sought to repel a tsunami of tourists , a neighborhood association in Santiago de Compostela opted for a friendlier approach: a guide to good manners for visitors to their town, the endpoint of the Catholic world's most famous pilgrimage.
Elon's $25 Trillion Confession - Ad
Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.
Apple's iPhone 17 Series Takes Off, Meta's New Smart Glasses And Major Partnerships In AI Space: This Week In AI
This weekend's tech roundup featured Apple's strong iPhone 17 launch in China and India, Meta's new smart glasses, major AI partnerships like Intel-Nvidia and PayPal-Google, and Jim Cramer questioning Huawei's chip breakthrough.
Mexico proposes new import taxes on 1,400 products to boost national production
MEXICO CITY (AP) — Mexico’s government submitted a budget proposal Tuesday that would impose new import taxes on more than 1,400 products — many from Asian nations — to strengthen national production at a time when the United States is pressuring its North American trade partner to .
The First Public Cash-Flowing Digital Treasury - Ad
Unlike Bitcoin vaults, this NASDAQ-listed company earns yield through BNB staking and nodes. $368M already deployed, still overlooked.
Cathie Wood Loads Up On Bullish Inc, Pony AI And Robinhood — Dumps Kratos Defense Amid Taiwan Drone Buzz
On Sept 17, 2025, Cathie Wood-led Ark Invest executed significant trades involving Bullish, Kratos Defense, Pony AI, and Robinhood. These reflect Ark's focus on emerging tech and defense sectors.
Ben & Jerry's Co-Founder Resigns In Protest As Politics Continue To Influence Corporate Exits
Jerry Greenfield, of Ben & Jerry's fame, didn't resign over personal controversy—he quit because his company stopped being political enough.
Digital Gold. Digital Oil. Digital Infrastructure. - Ad
Bitcoin and Ethereum had their turn. Now a NASDAQ-listed firm is scaling BNB, which fuels 290M users and pays yield.
Embed-Chart-Consumer Prices, ADVISORY
CONSUMER PRICES — Chart. This AP digital embed chart shows the percentage change in consumer prices from the previous year, as measured by the consumer price index, since 2010. In August, consumer prices rose 2.9%, up from July's 2.7% figure. Excluding food and energy, prices rose 3.1% from the previous year, unchanged from July. This chart is current as of Sept. 11, 2025, and will update monthly. Source: Bureau of Labor Statistics.
Opendoor Stock Rallies On Expansion And Short Squeeze Hopes
Opendoor stock rallied on Wednesday after it announced an expansion of U.S. operations, but it didn't specify which operations.
Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad
A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.
Family says a man who died after going on a Universal roller coaster never let wheelchair stop him
ORLANDO, Fla. (AP) — A 32-year-old man who from blunt impact injuries after going on a roller coaster at Universal Orlando Resort’s newest park used a wheelchair. But his family said it never stopped his unwavering spirit.
AP Exclusive: Russia, Vietnam using energy profits to avoid possible US sanctions for arms deals
BANGKOK (AP) — Russia and Vietnam have developed a back-door method of concealing arms deal payments to avoid American and other Western sanctions, using the profits from joint oil and gas ventures to pay off defense contracts without any open transfers of cash through the global banking system, according to internal Vietnamese documents obtained by The Associated Press.
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
Trump Links Sanctions On Russia To NATO Unity, Calls Out Hungary And Slovakia Over Oil Purchases
Trump stated that sanctions on Russia would only be imposed if all NATO countries agree to identical measures and halt Russian oil purchases.
Hillary Clinton Says Trump Administration Is 'Going Great' For The President, Dogecoin Rallies 20%, Silver Token Tops Bitcoin — This Week In Crypto
The past week has been a rollercoaster ride in the world of finance and politics. From silver-backed cryptocurrencies outperforming Bitcoin (CRYPTO: BTC) to Hillary Clinton’s accusations of crypto corruption against the Trump administration, there’s been no shortage of headlines.
The Next Evolution in Public Treasuries - Ad
MicroStrategy proved the model with BTC. Now a NASDAQ-listed firm is running it with BNB, yield, and 290M users. $368M locked in.
Trump's H-1B Visa Plan Stuns Big Tech, White House Says $100,000 Fee Is One-Time Only
The White House clarified that the $100,000 H-1B visa fee is a one-time charge, not an annual fee, amid confusion among major tech companies.
When self-doubt creeps in at work, pause and reframe your negative thoughts. Here's how
NEW YORK (AP) — When we make mistakes at work, it can lead to a cycle of negative thinking.
We've Seen This Before... and It Didn't End Well - Ad
Strange events are unfolding in the global financial system. A monetary reset dubbed the "Mar-a-Lago Accord" is quietly in motion, and the financial elite are already taking protective action. If history is any guide, you could lose up to 40% of your wealth in the next two years. Move your money before it's too late.
Anthony Scaramucci Says 'All Will Be Well' Amid NAKA Stock Volatility: David Bailey Admits 'Investors Are Down Money'
Anthony Scaramucci, the founder and managing partner of SkyBridge Capital, lent support to David Bailey on Tuesday, whose newly formed Bitcoin (CRYPTO: BTC) treasury company Kindly MD Inc. (NASDAQ:
Rigetti Computing Stock Soars On $5.8 Million Air Force Contract
Rigetti Computing Inc (NASDAQ:RGTI) shares are gaining traction on Thursday after the company announced a major quantum networking contract.
FDA Approval Could Send This Stock Soaring - Ad
Whenever the FDA approves a new drug... Timely investors could see 300-400% returns... ChemoCentryx soared 281% in the year after it won FDA approval... Immunogen jumped 449% in the two years after it won FDA approval... Even Krystal Biotech rose 242% when it looked like it would win FDA approval, which it did.
Economists Warn 'Stagflation Is In The Room' Amid Interest Rate Cut News: 'The Fed Has No Idea Where Inflation Will Be,' Says Peter Schiff
Leading economists are reacting to the Federal Reserve's decision to cut interest rates by 25 basis points on Wednesday, with some lauding the central bank's independence, and others warning of difficult times ahead.
Gov. Whitmer to address Michigan's economy as possible state and federal shutdowns loom
LANSING, Mich. (AP) — Three years ago, the story of Michigan was one of Democratic success. and Democratic state lawmakers of the executive and legislative branches of government.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Trump files $15 billion defamation lawsuit against The New York Times
NEW YORK (AP) — President Donald Trump filed a $15 billion defamation lawsuit against The New York Times and four of its journalists on Monday, according to court documents.
Co-Diagnostics Stock Plunges 28% In Pre-Market Despite Strategic Saudi Partnership
Co-Diagnostics (CODX) shares dropped 24.87% in pre-market trading after an 80.76% surge, despite announcing a strategic partnership.
Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
Elon Musk Back Atop Billionaires List, Tesla CEO Almost Recovers Lost Wealth Since Joining Hands With Trump
Elon Musk almost recovers wealth lost since aligning with Trump for 2024 election; now richest person thanks to surging Tesla stocks.
Meta Unveils $499 Oakley Vanguard And $799 Ray-Ban Display Smart Glasses At Connect 2025: Gene Munster Says 'Best Bang For The Buck'
Meta unveiled its $499 Oakley Vanguard and $799 Ray-Ban Display smart glasses at Connect 2025, with Gene Munster calling the Ray-Ban model the "best bang for the buck" as competition with Apple heats up.
Elon's $25 Trillion Confession - Ad
Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.
Edmunds small SUV comparison: 2026 Chevrolet Equinox vs. 2026 Hyundai Tucson
The and are two popular choices for shoppers looking at small SUVs. They’re also notable for their recent updates. The Equinox’s 2025 redesign ushers in more squared-off styling, technology and safety-related upgrades, and a new rugged-looking Activ trim level. The Tucson’s updates are milder but include refreshed styling and new tech features.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.